Algert Global LLC Surmodics Inc Transaction History
Algert Global LLC
- $4.25 Billion
- Q4 2024
A detailed history of Algert Global LLC transactions in Surmodics Inc stock. As of the latest transaction made, Algert Global LLC holds 14,260 shares of SRDX stock, worth $413,682. This represents 0.01% of its overall portfolio holdings.
Number of Shares
14,260
Previous 17,820
19.98%
Holding current value
$413,682
Previous $691,000
18.23%
% of portfolio
0.01%
Previous 0.02%
Shares
11 transactions
Others Institutions Holding SRDX
# of Institutions
141Shares Held
12.1MCall Options Held
31.4KPut Options Held
13.2K-
Black Rock Inc. New York, NY1.17MShares$34 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY1.01MShares$29.3 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA803KShares$23.3 Million0.0% of portfolio
-
Morgan Stanley New York, NY675KShares$19.6 Million0.0% of portfolio
-
Qube Research & Technologies LTD London, X0454KShares$13.2 Million0.02% of portfolio
About SURMODICS INC
- Ticker SRDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 14,005,000
- Market Cap $406M
- Description
- Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...